CRESCENT BIOPHARMA, INC. Earnings Per Share, Basic and Diluted
CRESCENT BIOPHARMA, INC. (CBIO) reported Earnings Per Share, Basic and Diluted of -$0.34 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-02.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-02
- CRESCENT BIOPHARMA, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.34.
- CRESCENT BIOPHARMA, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.28.
- CRESCENT BIOPHARMA, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.28.
- CRESCENT BIOPHARMA, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.29.
- CRESCENT BIOPHARMA, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.12.
- CRESCENT BIOPHARMA, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.34.
- CRESCENT BIOPHARMA, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.18.
- CRESCENT BIOPHARMA, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.13.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$0.34 10-Q · filed 2021-11-02 | -$0.90 10-Q · filed 2021-11-02 | ||
| 2021-06-30 | -$0.28 10-Q · filed 2021-08-05 | -$0.56 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | -$0.28 10-Q · filed 2021-05-03 | |||
| 2020-12-31 | -$1.12 10-K · filed 2021-03-02 | |||
| 2020-09-30 | -$0.29 10-Q · filed 2021-11-02 | -$0.79 10-Q · filed 2021-11-02 | ||
| 2020-06-30 | -$0.32 10-Q · filed 2021-08-05 | -$0.50 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$0.18 10-Q · filed 2021-05-03 | |||
| 2019-12-31 | -$0.34 10-K · filed 2020-02-28 | -$1.34 10-K · filed 2021-03-02 | ||
| 2019-09-30 | -$0.31 10-Q · filed 2020-11-06 | -$1.00 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | -$0.37 10-Q · filed 2020-07-31 | -$0.69 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | -$0.33 10-Q · filed 2020-05-01 | |||
| 2018-12-31 | -$0.32 10-K · filed 2020-02-28 | -$1.18 10-K · filed 2021-03-02 | ||
| 2018-09-30 | -$0.27 10-K · filed 2020-02-28 | -$0.85 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$0.26 10-K · filed 2020-02-28 | -$0.58 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | -$0.33 10-K · filed 2020-02-28 | |||
| 2017-12-31 | -$0.27 10-K · filed 2019-03-06 | -$1.13 10-K · filed 2020-02-28 | ||
| 2017-09-30 | -$0.24 10-K · filed 2019-03-06 | -$0.86 10-Q · filed 2018-11-02 | ||
| 2017-06-30 | -$0.30 10-K · filed 2019-03-06 | -$0.63 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | -$0.34 10-K · filed 2019-03-06 | |||
| 2016-12-31 | -$0.36 10-K · filed 2018-03-06 | -$1.50 10-K · filed 2019-03-06 | ||
| 2016-09-30 | -$0.34 10-K · filed 2018-03-06 | -$1.14 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | -$0.41 10-K · filed 2018-03-06 | -$0.80 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | -$0.40 10-K · filed 2018-03-06 | |||
| 2015-12-31 | -$0.67 10-K · filed 2018-03-06 | |||
| 2015-09-30 | -$0.38 10-Q · filed 2016-11-04 | -$0.20 10-Q · filed 2016-11-04 | ||
| 2015-03-31 | -$0.37 10-Q · filed 2016-05-04 | |||
| 2014-12-31 | -$0.60 10-K · filed 2017-03-01 | |||
| 2014-09-30 | -$0.35 10-Q · filed 2015-11-12 | -$0.20 10-Q · filed 2015-11-12 | ||
| 2014-03-31 | -$0.30 10-Q · filed 2015-05-05 | |||
| 2013-12-31 | -$8.87 10-K · filed 2016-02-29 | |||
| 2013-09-30 | -$3.00 10-Q · filed 2014-10-31 | -$6.50 10-Q · filed 2014-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |